★ America V2AuditLine ALPHA

AuditLine › HHS OIG › Centers for Medicare and Medicaid Services

HHS OIG recommendation 18-E-12-004.01

CMS should seek a legislative change that would provide the agency flexibility to determine when noncovered versions of a drug should be included in…

Closed Acceptable AlternativeThe publisher's status, as reported by HHS Office of Inspector General in the file read .

The recommendation, in the publisher's words

CMS should seek a legislative change that would provide the agency flexibility to determine when noncovered versions of a drug should be included in Part B payment amount calculations.
Responsible agency
Centers for Medicare and Medicaid Services
Issued
November 21, 2017
Report
Excluding Noncovered Versions When Setting Payment for Two Part B Drugs Would Have Resulted in Lower Drug Costs for Medicare and its Beneficiaries (OEI-12-17-00260) · find it at HHS OIG
Kind of report
Evaluation
Agency response
Non-Concur (as recorded by the publisher)
Closed
August 28, 2022 (publisher's date)
Publisher flags
Legislative
Publisher topics
Financial Stewardship, OIG Statutory Authority and Regulatory Matters, Prescription Drug

“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.

Dated history

  1. Issued by HHS OIG. (publisher's date)
  2. Closed, with status “Closed Acceptable Alternative”. (publisher's date)
  3. First recorded by AuditLine. (start of AuditLine's own history for this record)

Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.

Source

Open this report in HHS OIG's tracker This publisher's records (CSV)

Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows, SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.